Related Experiment Videos
In vitro toxicology: a commercial proposition?
1Imperial Chemical Industries PLC, Pharmaceutical Division, Macclesfield, Cheshire, UK.
Summary
Primary cell cultures offer accurate in vitro models for predicting chemical toxicity, balancing scientific rigor with commercial viability in compound development. These advanced toxicity tests save time, resources, and animals.
Area of Science:
- Toxicology
- In Vitro Testing
- Drug Development
Background:
- Scientific value of toxicity tests requires accurate in vivo modeling.
- Simple cell viability assays lack predictive power due to functional distance from animal tissues.
- Toxicity is a complex biological event.
Purpose of the Study:
- To evaluate primary cell cultures as superior in vitro models for toxicity prediction.
- To highlight the scientific and commercial advantages of using predictive in vitro toxicity tests.
- To advocate for the use of validated in vitro models in early-stage compound development.
Main Methods:
- Utilizing primary cell cultures (hepatocytes, nerve cells, embryo cells) that retain or acquire differentiated functions.
- Comparing the predictive accuracy of primary cultures against simple cell viability tests.
- Assessing the utility of in vitro models for Quantitative Structure-Activity Relationship (QSAR) studies.
Main Results:
- Primary cultures serve as optimal models for predicting toxic hazards due to retained differentiated functions.
- In vitro tests, when validated, offer significant commercial benefits, including time and cost savings.
- In vitro methods facilitate mechanistic toxicity studies and reduce animal usage.
Conclusions:
- Primary cell cultures are the preferred in vitro models for accurate toxicity hazard prediction.
- Validated in vitro toxicity testing provides both scientific and commercial advantages.
- In vitro approaches enhance compound development efficiency and reduce reliance on animal testing.